The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

The First in China! BLA Submitted for Luzhu Biotech's Recombinant Herpes Zoster Vaccine Expected to Be Launched in 2026 HONG KONG ...

The growth of the vaccine technologies market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare, and government immunization programs and initiatives.

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Vaccines dominate the poultry pharmaceuticals market due to rising concerns over infectious diseases like Newcastle Disease and Avian Influenza. Regulatory restrictions on antibiotics further boost ...

META_DESC_INVESTMENT_IDEA ...

Founded in 1987 in the US, Gale Smith – VP of vaccine development at Novavax – invented the technique of using insect cells for producing recombinant protein vaccines. A further milestone came ...

Trump has shut down the USAID work saying that it was not aligned with American strategic interests and wastes money.

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public health interest.